Feng Zhan Zhang

Goldman Sachs (Singapore) Pte. (Goldman Sachs-Singapore) is the brokerage subsidiary of New York-based Goldman Sachs Group, Inc. (NYSE: GS), a global investment bank that offers financial services to corporations, institutions, governments and high-net worth individuals. Headquartered in Singapore, the firm opened in 1989 and is the regional hub for the group's activities in Southeast Asia, particularly asset management and energy trading. Goldman Sachs-Singapore provides a full range of corporate finance and capital markets products and services across a wide range of operating areas. Business functions include capital structuring advisory, and security services.

Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally.

Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors.

BOC International (China) Ltd. (Broker) (BOC Broker) is the brokerage division of BOC International (China) Ltd. The firm is headquartered in Shanghai and was founded in 2002. BOC Broker provides brokerage services to their clients.

China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China.

Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China.

Part of Yuanta Financial Holding Co. Ltd., Yuanta Securities Investment Consulting Co., Ltd. is a financial services company based in Taipei, Taiwan. Yuanta Securities Investment Consulting Co. is committed to innovation in products and services, using artificial intelligence and big data technology to provide intelligent stock selection and order placement tools, creating a one-stop mobile service for purchasing, and actively expanding business in Taiwan, China, and Hong Kong, with the aim of becoming the leading securities firm in Asia for Chinese people. The Taiwanese company also offers regular and fixed purchases of US stocks, with a maximum handling fee of only $1, making it easy for customers to become international shareholders. The company was founded in 1961. Vincent Chen has been the CEO of the company since 2011.

DBS Vickers (Hong Kong) Ltd. (DBS-HK) is a broker/dealer firm headquartered in Hong Kong. The firm is a subsidiary of DBS Vickers Securities Holdings Pte Ltd., ultimately held by DBS Group Holdings Ltd. (SGX: D05) in Singapore. DBS-HK provides a comprehensive blend of brokerage services.

UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals.

Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller.

Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments.

Yuanta Securities (Hong Kong) Co., Ltd. (YSHK) is a brokerage firm headquartered in Hong Kong. The firm is a wholly-owned subsidiary of Yuanta Securities Asia Financial Services Ltd., ultimately owned by Yuanta Financial Holding Co. Ltd. (TPE: 2885) in Taiwan. YSHK provides brokerage services to global and local institutional clients, corporate clients as well as individual investors.

SWS Research Co., Ltd. is the investment research subsidiary of Shenwan Hongyuan Securities Co., Ltd., which is owned by Shenwan Hongyuan Group Co., Ltd. (SHE: 000166) in China. Headquartered in Shanghai, the firm was founded in 1992 to offer a wide range of products and services to global investors who want to invest in Chinese equity market. SWS Research provides clients with securities research service that covers over 500 key stocks in Asian market, as well as economics, strategy, bond, fund and derivatives research. Their clients include almost all major domestic institutional investors such as mutual funds, insurance companies, banks and trusts. They also serve QFII and other overseas institutional investors.

Beijing Gao Hua Securities Co., Ltd. is a financial services company based in Beijing, China. and has subsidiaries in China. The company's description is written in Chinese, but it appears to offer a range of financial services, including securities trading, investment banking, and asset management. The private company's website includes information about its history, services, and team, as well as news and research reports. The company was founded in 2004, and Xing Zhang has been the CEO of the company since 2004.

Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research.

Part of Bank of America Corp., Merrill Lynch Securities (Taiwan) Ltd. is a brokerage service provider. The company is based in Taipei, Taiwan. Merrill Lynch Securities (Taiwan was founded in 2008.

Evalueserve Business Consulting (Shanghai) Co., Ltd. (Evalueserve Shanghai) is an AI-enhanced managed services global provider headquartered in Shanghai, China. The firm was founded in 2005 and is owned by Evalueserve, Inc. in the US. More than 30% of the Fortune 1000, which includes over 25,000 platform users, rely on Evalueserve’s intelligence and analytics to strengthen and accelerate decision-making. Their solutions uniquely combine expert services with domain-specific AI and have been recognized by analysts such as Forrester and Chartis. Evalueserve’s solutions include data analytics, insights and advisory, intellectual property and R&D, investment banking services, lending services, private equity services, and risk and compliance. These solutions are powered by Evalueserve’s modular AIRA (AI for Research and Analytics) ecosystem, which includes domain-specific accelerators, products, and platforms. Evalueserve experts use these tools to reduce time to value and integrate new solutions into existing workflows. Notable products and platforms include Insightsfirst, Insightloupe, Publishwise, Spreadsmart, and Compsbuilder. The firm supports three categories of firms: financial services, corporates, and professional services. Specifically, this includes Investment Banks, Corporate and Commercial Banks, Asset and Wealth Management Firms, Private Equity and Venture Capital Firms, Index Providers, Technology and Telecom, Life Sciences and Healthcare, Manufacturing and Industrial Goods, Energy, Chemicals, CPG and Retail, Logistics and Transportation, Professional Service Firms, Consultancy and Advisory Firms, Legal Firms, Real Estate Firms, Education and EdTech Firms.

Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China.

Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu.

Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China.

Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.

Shanghai Hongshang Investment Co., Ltd. operates as an investment holding company. Its business activities include industrial investment, investment management and consultation, asset management, and import and export business. The company was founded on November 5, 2015 and is headquartered in Shanghai, China.

HSBC Qianhai Securities Ltd. combines the global platform of HSBC Group with the local resources of Qianhai Financial Holdings to provide clients with a comprehensive range of securities products and services. HSBC Qianhai Securities is based in Shenzhen, CN. The Chinese company is committed to providing professional, diverse, and customized wealth management services to high-net-worth and ultra-high-net-worth clients and their families. With a global perspective, the company has insights into the Chinese A-share market. The joint venture company was founded in 2017, and the CEO is Irene Ho.

Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom.

Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China.

Zhejiang Haichang Bio-Tech Co., Ltd. is a national high-tech enterprise located in Hangzhou, China. The Chinese company specializes in research and development of biopharmaceutical technology, with independent innovation capabilities and global intellectual property rights. It was founded in 2013 by Xiao Bin Zhao.

Focus & Fusion Healthcare Co. Ltd. is a Chinese company that manufactures clinical diagnostic equipment. The company is located in China.